Physician profile
David G Marsh
NPI 1720239395
$6,296.40
in general payments reported to CMS, 2019-2025
9 companies · $2,613 in 2025
The $2,613 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $1,320 · 2021: $296 · 2022: $1,107 · 2023: $18.00 · 2024: $707 · 2025: $2,613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,914 · Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,914.43 |
| Food and Beverage | $423.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,732.57 | 2019-2025 | |
| Nexus Medical Technologies LLC | $1,544.69 | 2025 | |
| Rock Medical Orthopedics, INC. | $874.57 | 2020-2024 | |
| Vericel Corporation | $40.14 | 2022-2023 | Maci |
| Stryker Corporation | $33.67 | 2025 | Pangea |
| Depuy Synthes Sales INC. | $23.99 | 2021 | |
| Bioventus LLC | $22.98 | 2024 | Exogen Ultrasound Bone Healing System |
| Medline Industries LP | $12.88 | 2021 | |
| Zimmer Biomet Holdings, INC. | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Marsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.